The Cell and Gene Therapy CDMO Market growth is driven by the increasing demand for personalized medicine and targeted therapies. Cell and gene therapies offer the potential to treat diseases at the genetic level, providing long-term or even permanent solutions. This has led to a surge in research and development activities, creating a strong demand for CDMO services. The need for scalable and cost-effective manufacturing solutions is further encouraging companies to partner with CDMOs.

Additionally, advancements in bioprocessing technologies and automation are improving manufacturing efficiency and reducing production costs. The integration of artificial intelligence and data analytics is also enhancing process optimization and quality control. The growing trend of strategic partnerships and collaborations between pharmaceutical companies and CDMOs is strengthening the market ecosystem. These factors are contributing to the steady growth and development of the market.

FAQ

Q1. What drives market growth?
Personalized medicine and advanced therapies.

Q2. What are key trends?
Automation and AI integration.